Yuyu Pharma Cash Flow-to-Debt Ratio
Yuyu Pharma cash flow-to-debt ratio. Yuyu Pharma (000220) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩836.62 Million could theoretically repay 0% of its total liabilities (₩63.32 Billion) in one year. Check 000220 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Yuyu Pharma (2011–2024)
Cash flow-to-debt ratio of Yuyu Pharma from 2011 to 2024. Historical debt coverage capacity for Yuyu Pharma across 14 annual periods. Check earnings quality score of Yuyu Pharma to evaluate the quality of earnings relative to operating cash generation.
Yuyu Pharma Cash Flow-to-Debt Ratio by Year (2011–2024)
Yuyu Pharma cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Yuyu Pharma. For the full cash flow conversion analysis, see cash flow conversion of Yuyu Pharma.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩24.95 Billion | ₩72.62 Billion | ▲ +6255.6% |
| 2023 | 0.01x | ₩420.86 Million | ₩77.86 Billion | ▲ +106.2% |
| 2022 | -0.09x | ₩-6.23 Billion | ₩71.83 Billion | ▼ -223.7% |
| 2021 | 0.07x | ₩4.51 Billion | ₩64.30 Billion | ▲ +199.5% |
| 2020 | -0.07x | ₩-2.67 Billion | ₩37.86 Billion | ▼ -125.2% |
| 2019 | 0.28x | ₩13.19 Billion | ₩47.17 Billion | ▲ +121.2% |
| 2018 | 0.13x | ₩6.11 Billion | ₩48.35 Billion | ▲ +770.2% |
| 2017 | 0.01x | ₩561.35 Million | ₩38.66 Billion | ▼ -95.1% |
| 2016 | 0.30x | ₩9.82 Billion | ₩33.01 Billion | ▲ +177.9% |
| 2015 | -0.38x | ₩-11.68 Billion | ₩30.60 Billion | ▼ -937.8% |
| 2014 | 0.05x | ₩1.36 Billion | ₩29.91 Billion | ▲ +241.1% |
| 2013 | -0.03x | ₩-775.17 Million | ₩23.99 Billion | ▼ -109.5% |
| 2012 | 0.34x | ₩6.51 Billion | ₩19.18 Billion | ▲ +8.2% |
| 2011 | 0.31x | ₩6.67 Billion | ₩21.28 Billion | — |